Up to 80% of breast cancer deaths occur in patients with tumors that express estrogen receptor-alpha, according to a study published in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research.
In June 2020, I was seeing consults in the damp, windowless basement of a community hospital in North Carolina.
